• WUXI PHARMATECH CAYMAN INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY FY
    Assets
    Cash and Short Term Investments 219.11 M 183.10 M 5.49 M
    Net Receivables 18.20 M 12.73 M 4.85 M
    Total Inventories 13.35 M 9.62 M 3.39 M
    Progress Payments & Others 0.00 0.00 0.00
    Prepaid Expenses 5.21 M 1.82 M 306,210.91
    Other Current Assets 6.00 M 734,073.01 477,003.86
    Current Assets Total 261.88 M 208.01 M 14.51 M
    Long Term Receivables 0.00
    Investment in Unconsolidated Subsidiaries 0.00
    Other Investments 0.00 359,636.01 247,125.93
    Property, Plant & Equipment Net 73.64 M 47.42 M 25.06 M
    Property, Plant & Equipment Gross 88.84 M 54.33 M 28.20 M
    Accumulated Depreciation 15.20 M 6.91 M 3.14 M
    Other Assets 7.80 M 628,442.01 586,014.83
    Deferred Charges 0.00 0.00 0.00
    Tangible Other Assets 1.72 M 0.00 0.00
    Intangible Other Assets 6.08 M 628,442.01 586,014.83
    Total Assets 343.31 M 256.41 M 40.40 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 4.50 M 9.70 M
    Accrued Payroll
    Income Taxes Payable 4.06 M 64,582.00 359,651.89
    Dividends Payable 742,112.78
    Other Current Liabilities 34.29 M 11.67 M 5.96 M
    Current Liabilities Total 45.57 M 25.49 M 18.45 M
    Long Term Debt 45.09 M 46.40 M 5.04 M
    Provision for Risks & Charges
    Deferred Taxes -282,020.06 -503,597.01 -337,304.90
    Deferred Income
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 1.03 M 0.00
    Total Liabilities 90.38 M 72.41 M 23.16 M
    Shareholders Equity
    Non-Equity Reserves 1.53 M
    Minority Interest 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00
    Common Equity 251.40 M 184.00 M 17.24 M
    Common Stock 9.84 M 9.90 M
    Capital Surplus 291.02 M 257.60 M
    Revaluation Reserves 0.00
    Other Appropriated Reserves 7.84 M
    Unappropriated (Free) Reserves
    Retained Earnings -57.30 M -85.20 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00
    Unrealized Foreign Exchange Gain (Loss) 2.10 M
    Unrealized Gain (Loss) on Marketable Securities 0.00
    Treasury Stock 0.00 400,000.01
    Total Liabilities & Shareholders Equity 343.31 M 256.41 M 40.40 M
    Common Shares Outstanding